Nicotinamide: A vitamin able to shift macrophage differentiation toward macrophages with restricted inflammatory features

Innate Immunity

Volumn 21, Issue 8, 2015, Pages 813-826

  Weiss, Ronald ^a,b   Schilling, Erik ^a,b   Grahnert, Anja ^a,b   Kölling, Valeen ^a,b   Dorow, Juliane ^a,b   Ceglarek, Uta ^a,b   Sack, Ulrich ^a,b   Hauschildt, Sunna ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Inflammation; LPS; macrophages; NF B; nicotinamide

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOCHROME P450; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NICOTINAMIDE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; VITAMIN B COMPLEX;

ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MONOCYTE; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELLS, CULTURED; EICOSANOIDS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; NAD; NF-KAPPA B; NIACINAMIDE; SIGNAL TRANSDUCTION; VITAMIN B COMPLEX;

EID: 84945191473     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425915602545     Document Type: Article

References (49)

1. Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S,. Enzymology of NAD+ synthesis. Adv Enzymol Relat Areas Mol Biol 1999; 73: 135-182.
2. Avalos JL, Bever KM, Wolberger C,. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 2005; 17: 855-868.
3. Belenky P, Bogan KL, Brenner C,. NAD+ metabolism in health and disease. Trends Biochem Sci 2007; 32: 12-19.
4. Blander G, Guarente L,. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004; 73: 417-435.
5. Hassa PO, Hottiger MO,. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 2008; 13: 3046-3082.
6. Michan S, Sinclair D,. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404: 1-13.
7. Bernier J, Stratford MR, Denekamp J, Dennis MF, Bieri S, Hagen F, et al. Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. Radiother Oncol 1998; 48: 123-133.
8. Heine H, Ulmer AJ, Flad HD, Hauschildt S,. Lipopolysaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. J Immunol 1995; 155: 4899-4908.
9. Niren NM,. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. Cutis 2006; 77: 11-16.
10. Skokowa J, Lan D, Thakur BK, Wang F, Gupta K, Cario G, et al. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat Med 2009; 15: 151-158.
11. Martinez FO, Gordon S,. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014; 6: 13-13.
12. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD,. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007; 178: 5245-5252.
13. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004; 101: 4560-4565.
14. Hamilton TA, Zhao C, Pavicic PG Jr., Datta S,. Myeloid colony-stimulating factors as regulators of macrophage polarization. Front Immunol 2014; 5: 554-554.
15. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM, et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol 2012; 188: 5752-5765.
16. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009; 114: 3244-3254.
17. Mia S, Warnecke A, Zhang XM, Malmstrom V, Harris RA,. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol 2014; 79: 305-314.
18. Grage-Griebenow E, Lorenzen D, Fetting R, Flad HD, Ernst M,. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol 1993; 23: 3126-3135.
19. Rossol M, Gartner D, Hauschildt S,. Diverse regulation of microfilament assembly, production of TNF-alpha, and reactive oxygen intermediates by actin modulating substances and inhibitors of ADP-ribosylation in human monocytes stimulated with LPS. Cell Motil Cytoskeleton 2001; 48: 96-108.
20. Kortz L, Dorow J, Becker S, Thiery J, Ceglarek U,. Fast liquid chromatography-quadrupole linear ion trap-mass spectrometry analysis of polyunsaturated fatty acids and eicosanoids in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 927: 209-213.
21. Thiele A, Wasner M, Muller C, Engeland K, Hauschildt S,. Regulation and possible function of beta-catenin in human monocytes. J Immunol 2001; 167: 6786-6793.
22. Grahnert A, Friedrich M, Pfister M, Haag F, Koch-Nolte F, Hauschildt S,. Mono-ADP-ribosyltransferases in human monocytes: regulation by lipopolysaccharide. Biochem J 2002; 362: 717-723.
23. Grahnert A, Richter S, Siegert F, Berndt A, Hauschildt S,. The orthologue of the 'acatalytic' mammalian ART4 in chicken is an arginine-specific mono-ADP-ribosyltransferase. BMC Mol Biol 2008; 9: 86-86.
24. Van der Does AM, Beekhuizen H, Ravensbergen B, Vos T, Ottenhoff TH, van Dissel JT, et al. LL-37 directs macrophage differentiation toward macrophages with a pro-inflammatory signature. J Immunol 2010; 185: 1442-1449.
25. Aznar C, Fitting C, Cavaillon JM,. Lipopolysaccharide-induced production of cytokines by bone marrow-derived macrophages: dissociation between intracellular interleukin 1 production and interleukin 1 release. Cytokine 1990; 2: 259-265.
26. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267: 25934-25938.
27. Van Gool F, Galli M, Gueydan C, Kruys V, Prevot PP, Bedalov A, et al. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 2009; 15: 206-210.
28. Taylor DM, Maxwell MM, Luthi-Carter R, Kazantsev AG,. Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci 2008; 65: 4000-4018.
29. Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009; 136: 62-74.
30. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380.
31. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425: 191-196.
32. Chen LF, Greene WC,. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
33. Kao SJ, Liu DD, Su CF, Chen HI,. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin. J Cardiovasc Pharmacol 2007; 50: 333-342.
34. Ungerstedt JS, Blomback M, Soderstrom T,. Nicotinamide is a potent inhibitor of pro-inflammatory cytokines. Clin Exp Immunol 2003; 131: 48-52.
35. Revollo JR, Grimm AA, Imai S,. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 2004; 279: 50754-50763.
36. Imai S,. A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol Res 2010; 62: 42-47.
37. Virag L,. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol 2005; 3: 209-214.
38. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 2010; 185: 605-614.
39. Schilling E, Wehrhahn J, Klein C, Raulien N, Ceglarek U, Hauschildt S,. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes. Innate Immun 2012; 18: 518-530.
40. Liu TF, Yoza BK, El GM, Vachharajani VT, McCall CE,. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem 2011; 286: 9856-9864.
41. Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1047-G1053.
42. Le Page C, Sanceau J, Drapier JC, Wietzerbin J,. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun 1998; 243: 451-457.
43. Hassa PO, Hottiger MO,. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 2002; 59: 1534-1553.
44. Bai P, Virag L,. Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes. FEBS Lett 2012; 586: 3771-3777.
45. Norris PC, Reichart D, Dumlao DS, Glass CK, Dennis EA,. Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype. J Leukoc Biol 2011; 90: 563-574.
46. Tilley SL, Coffman TM, Koller BH,. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15-23.
47. Inoue H, Tanabe T,. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 1998; 244: 143-148.
48. Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR,. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 2000; 275: 6259-6266.
49. Stehr A, Ploner F, Tugtekin I, Matejovic M, Theisen M, Zulke C, et al. Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia. Intensive Care Med 2003; 29: 995-1002.